Items

The use of unproven drugs for COVID-19 treatment in people living with HIV. (2023-06)

J. Kowalska, B. Rozplochowski, A. Harxhi, L. Fleischhans, S. Antonjak, D. Gokengin, A. Vassilenko, K. Almla, A. Papadopoulus, R. Matulionyte, N. Rukhadze, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, A. Verhaz, N. Yancheva, J. Begovac, A. Skrzat-Klapaczyńska, C. Oprea, A. Horban, The use of unproven drugs for COVID-19 treatment in people living with HIV., Jun, 2023
Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2022)

J. Kowalska, D. Bursa, D. Jilich, S. Antoniak, M. Lara, N. Bogdanić, D. Gokengin, C. Oprea, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, L. Fleishhans, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, A. Skrzat-Klapaczyńska, Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group, 18th EACS 2021, 2022
Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19) (2021-12)

B. Lakatos, J. Kowalska, S. Antoniak, D. Gokengin, J. Begovac, A. Vassilenko, p. wasilevski, l. fleischhans, D. Lakatos, R. Matulionyte, K. Kase, A. Papadopoulus, N. Rukhadze, A. Harxhi, S. Hofman, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, C. Oprea, Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19), HIV MEDICINE, Vol. 23, No. 1468-1293, pp. 1 - 8, Dec, 2021
The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group (2022-05)

J. Kowalska, C. Bienkowski, L. Fleishhans, S. Antoniak, A. Skrzat-Klapaczyńska, M. Suchacz, N. Bogdanić, D. Gokengin, C. Oprea, I. Karpov, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, D. Jilich, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Jancheva, J. Begovac, A. Horban, The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group, STED Journal, Vol. 14, No. 5, pp. 1 - 12, May, 2022
The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group (2022-06)

A. Skrzat-Klapaczyńska, J. Kowalska, S. Antonyak, T. Balayan, J. Begovac, D. Bursa, G. Dragović-Lukić, D. Gokengin, L. Afonina, A. Harxhi, D. Jilich, K. Kase, A. Verhaz, B. Lakatos, M. Mardarescu, R. Matulionyte, A. Panteleev, A. Papadopoulus, L. Sojak, C. Oprea, J. Tomazic, A. Vassilenko, M. Vasyliev, A. Verhaz, N. Yancheva, O. Yurin, A. Horban, The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, Vol. 19 (13), No. 19(13), pp. 1 - 9, Jun, 2022
Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries—Cross-Sectional Analysis from the ECEE Network (2022-10)

B. Matlosz, A. Skrzat-Klapaczyńska, S. Antoniak, T. Balayan, J. Begovac, G. Dragović-Lukić, D. Gusey, Đ. Jevtović, D. Jilich, K. Aimla, B. Lakatos, R. Matulionyte, A. Panteleev, A. Papadopoulus, N. Rukhadze, M. Stevanović, D. Sedlacek, A. Vassilenko, A. Verhaz, N. Yancheva, O. Yurin, A. Horban, J. Kowalska, Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries—Cross-Sectional Analysis from the ECEE Network, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, Vol. 19, pp. 1 - 12, Oct, 2022
Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023)

A. Kerstin, J. Kowalska, R. Matulionyte, V. Mulabdic, A. Vassilenko, N. Bolokadze, D. Jilich, S. Antoniak, C. Oprea, T. Balayan, A. Harxhi, A. Papadopoulus, B. Lakatos, M. Vasylyev, J. Begovac, N. Yancheva, A. Streinu-Cercel, A. Verhaz, D. Gokengin, G. Dragović-Lukić, L. Sojak, A. Skrzat-Klapaczyńska, Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group, EXPERT REVIEW OF VACCINES, Vol. 11, pp. 1 - 9, 2023
PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future (2023-01)

D. Gokengin, D. Bursa, A. Skrzat-Klapaczyńska, I. Alexiev, E. Arsikj, T. Balayan, J. Begovac, A. Cicic, G. Dragović-Lukić, A. Harxhi, K. Aimla, B. Lakatos, R. Matulionyte, V. Mulabdić, C. Oprea, A. Papadopoulus, N. Rukhadze, D. Sedlacek, L. Sojak, J. Tomazic, A. Vassilenko, M. Vasyliev, A. Verhaz, A. Verhaz, N. Yancheva, O. Yurin, J. Kowalska, PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future, Vaccines , Vol. 11, No. 1, pp. 1 - 12, Jan, 2023
Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023-05)

A. Kerstin, J. Kowalska, R. Matulionyte, V. Mulabdić, A. Vassilenko, N. Bolokadze, D. Jilich, S. Antoniak, C. Oprea, T. Balayan, A. Harxhi, A. Papadopoulus, B. Lakatos, M. Vasylyev, J. Begovac, N. Yancheva, A. Streinu-Cercel, D. Gokengin, A. Verhaz, G. Dragović-Lukić, Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group, STED Journal, Vol. 11(5), pp. 980 - 987, May, 2023
Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2021-10)

J. Kowalska, D. Bursa, D. Jilich, S. Antonjak, M. Lara, N. Bogdanić, D. Gokengin, C. Oprea, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, A. Verhaz, Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group, 18th EACS 2021, ePoster. PE4/18ecee.president@gmail.com, Oct, 2021
Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group (2022-07)

J. Kowalska, M. Vasyliev, A. Harxhi, L. Fleischhans, S. Antoniak, D. Gokengin, A. Vassilenko, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, B. Lakatos, G. Dragović-Lukić, D. Jilich, A. Verhaz, A. Verhaz, J. Begovac, A. Skrzat-Klapaczyńska, C. Oprea, Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group, Jul, 2022
Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group (2022-11)

J. Kowalska, C. Bieńkowski, L. Fleischhans, S. Antonjak, A. Skrzat-Klapaczyńska, M. Suchacz, N. Bogdanić, D. Goengin, C. Oprea, I. Karpov, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, D. Jilich, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, . Horban, Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group, Nov, 2022

Items

The use of unproven drugs for COVID-19 treatment in people living with HIV. (2023-06)

Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2022)

Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19) (2021-12)

The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group (2022-05)

The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group (2022-06)

Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries—Cross-Sectional Analysis from the ECEE Network (2022-10)

Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023)

PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future (2023-01)

Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group (2023-05)

Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group (2021-10)

Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group (2022-07)

Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group (2022-11)